Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

135
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
135
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

519
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
519
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

584
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
584
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of artificial sweeteners intake and risk of CKD: a prospective cohort study.

The journal of nutrition, health & aging·2026
Same author

Multiomics reveals fatty acid metabolism and immune remodeling in retinal artery occlusion.

iScience·2026
Same author

Non-pharmacological therapies for patients with lymphangioleiomyomatosis: a systematic review and meta-analysis.

Frontiers in rehabilitation sciences·2026
Same author

Online Intervention on Lung Cancer Screening Among High-Risk Individuals: Pilot Intervention Study.

JMIR cancer·2026
Same author

Associations between female sex-specific risk factors and cardiometabolic multimorbidity: evidence from the UK Biobank cohort study.

BMC public health·2026
Same author

[A Single Center Real-World Study of the Efficacy of Daratumumab-Based Regimens in the Treatment of Relapsed/Refractory Multiple Myeloma Patients].

Zhongguo shi yan xue ye xue za zhi·2026

Related Experiment Video

Updated: Jun 12, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

Elevated high-density lipoprotein triglycerides increase atherosclerotic risk.

Weifang Liu1, Shaoze Chen2, Chengzhang Yang2

  • 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China; State Key Laboratory of New Drug Discovery and Development for Major Diseases, Gannan Medical University, Ganzhou, China; Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, China.

Journal of Lipid Research
|March 31, 2025
PubMed
Summary

High triglycerides alter high-density lipoprotein (HDL) function, increasing coronary artery disease (CAD) risk. Elevated triglycerides within HDL particles (HDL-TG) are a key risk factor, potentially causal, suggesting omega-3 fatty acids as a therapeutic strategy.

Keywords:
coronary artery diseasehigh-density lipoproteinmendelian randomizationomega-3 fatty acidstriglycerides in high-density lipoprotein

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.0K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Related Experiment Videos

Last Updated: Jun 12, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.0K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Genetics

Background:

  • High-density lipoprotein (HDL) particle heterogeneity complicates understanding its role in atherosclerotic risk.
  • Hypertriglyceridemia is linked to changes in HDL composition and function.
  • The specific impact of elevated triglycerides on HDL and coronary artery disease (CAD) risk requires further elucidation.

Purpose of the Study:

  • To investigate how elevated triglycerides affect HDL composition and size.
  • To determine the association between altered HDL and CAD risk.
  • To explore the causal role of HDL triglycerides (HDL-TG) in CAD development and potential therapeutic targets.

Main Methods:

  • Analysis of a large prospective cohort study examining HDL parameters and CAD events.
  • Mendelian randomization (MR) analyses to assess the causal relationship between HDL-TG and CAD.
  • Drug-target MR to identify potential pharmacological interventions.

Main Results:

  • Elevated triglycerides correlated with smaller HDL particle size, reduced HDL components, and increased HDL-TG.
  • The protective effect of HDL on CAD risk diminished with rising triglyceride levels.
  • Higher HDL-TG levels independently predicted incident CAD events and were causally linked to CAD development via MR.
  • Omega-3 fatty acids (OM3-FA) showed a potential association with lower HDL-TG, implicating LPL and DGAT2.

Conclusions:

  • Elevated triglycerides adversely modify HDL, increasing CAD risk.
  • HDL-TG is an independent positive risk factor and potential causal agent in CAD.
  • OM3-FA supplementation may be a viable strategy to reduce CAD risk associated with elevated HDL-TG.